510(k) Report

510(k) · Cleared

Cleared

Glucose2

K252357510(k) TraditionalCleared Oct 24, 202587-day reviewClass II21 CFR 862.1345

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Ireland · CFR Hexokinase, Glucose

Cleared on Oct 24, 2025 as substantially equivalent to K060383 (Abbott Laboratories, 2006) after an 87-day review. Its family tree reaches back 2 generations to 1996.

Decided
Oct 24, 2025
Review
87 days
Class
Class II
Product code
CFR
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K953847 (1996). No later device cites it as a predicate yet.

  1. Root · 2 generations backK953847 Roche Reagent for GlucoseRoche Diagnostic Systems, Inc. · 1996
  2. 1 generation backK060383 GlucoseAbbott Laboratories · 2006
  3. This deviceK252357 Glucose2Abbott Ireland · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K953847Roche Reagent for GlucoseRoche Diagnostic Systems, Inc.1996—
−1K060383GlucoseAbbott Laboratories2006—
0 (this device)K252357Glucose2Abbott Ireland2025—
FIG. 1 — Lineage of K252357, 1996–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CFR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CFR device

  1. #1 K253490 Glucose HK Gen.3; ONLINE DAT Methadone II…score 11.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K060383Glucose
Summary page 6
…Classification: Class II Classification Name: Glucose Test System Regulation Number: 21 CFR §862.1345 Product Code: CFR III. Predicate Device Glucose; k060383 IV. Description of Device A. Principles of the Procedure The Glucose2 assay is an automated clinical chemistry ass…
Abbott Laboratories2006—

Also cleared against K060383: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 29 years and passes through 3 companies; a new generation was cleared every 19.5 years on median.
  • None of the 2 ancestors has a recall.
  • 1 other device also cites its predicate K060383.

How does its category compare?

All CFR devices

CFR Hexokinase, Glucose: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · CFR

1in 2025

2007: 12008: 52009: 32011: 32012: 42013: 12014: 12016: 22017: 12019: 12022: 12025: 12026 (partial year): 1
2007high 5 (2008) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CFR

115in 2012

2008: 182 days median2009: 101 days median2011: 316 days median2012: 115 days median
2007high 316 (2011) · low 101 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CFR

1in 2016

2008: 72009: 12012: 12014: 12016: 1
2007high 7 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CFR

16in 2025

2007: 12008: 22009: 72010: 112011: 432012: 492013: 362014: 22015: 32016: 12017: 132018: 82019: 102020: 42021: 52022: 32023: 292024: 152025: 16
2007high 49 (2012) · low 1 (2007)2025

MAUDE reports naming product code CFR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—01
2008518272
2009310117
20100—011
20113316043
20124115149
20131—036
20141—12
20150—03
20162—11
20171—013
20180—08
20191—010
20200—04
20210—05
20221—03
20230—029
20240—015
20251—016
20261—0—

What is it indicated for?

The Glucose2 assay is used for the quantitation of glucose in human serum, plasma, urine, or cerebrospinal fluid (CSF) on the ARCHITECT c System.

Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K252357: Glucose2.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K252357

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026